Marie-Anne Petit

Title: Marie-Anne Petit: Innovator in Hepatitis C Research

Introduction

Marie-Anne Petit is a prominent inventor based in Bron, France. She has made significant contributions to the field of medical research, particularly in the development of antibodies against the hepatitis C virus. With a total of 2 patents, her work has the potential to impact the treatment and understanding of this viral infection.

Latest Patents

Her latest patents focus on antibodies directed against the hepatitis C virus E1E2 complex. These patents include compositions of HCV particles and pharmaceutical compositions. The new conformational antibodies are specifically designed to target HCV, particularly through the use of monoclonal antibodies. The described compositions of particles are capable of being recognized by these antibodies, as are the pharmaceutical compositions that contain them. Additionally, her patents detail HCV enveloped subviral particles and purified HCV enveloped complete viral particles, along with the processes for preparing them.

Career Highlights

Marie-Anne Petit has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and bioMérieux SA. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Colette Jolivet-Reynaud and Christian Trepo. Their collaborative efforts have further advanced the understanding of hepatitis C and the development of effective treatments.

Conclusion

Marie-Anne Petit is a key figure in the fight against hepatitis C, with her innovative patents paving the way for new therapeutic approaches. Her dedication to research and collaboration with other experts highlights the importance of teamwork in scientific advancements.